www.fdanews.com/articles/134173-alexion-buys-patents-from-german-biotech-for-infant-disorder

Alexion Buys Patents From German Biotech for Infant Disorder

February 10, 2011

Pharmaceuticals Inc. acquired patents and assets for a possible therapy for a ultra-rare genetic disorder for $3 million in cash from Germany-based Orphatec Pharmaceuticals GmbH.
Mass High Tech